Canadian Hematology Today

Articles

• 

  New Developments in the Front‑line Treatment of Advanced Stage Classic Hodgkin Lymphoma: A Canadian Perspective

  Jowon L. Kim, MD, Kerry J. Savage, MD

  5–17

  • PDF (en)
  • PDF (fr)
• 

  Practical Management of Aggressive B-Cell Lymphomas with CD20×CD3 Bispecific Antibodies

  Christopher Lemieux, MD, FRCPC, DRCPC

  19–22

  • PDF (en)
  • PDF (fr)
• 

  Unique Toxicities of Novel Myeloma Therapies: Focus on Belantamab Mafodotin, Talquetamab, and Selinexor

  Jesse Shustik, MD, FRCPC

  24–35

  • PDF (en)
  • PDF (fr)
• 

  Rational Use of Immunoglobulin in Adult Patients with Secondary Hypogammaglobulinemia in the Setting of Hematologic Malignancy: A Canadian Perspective

  Oksana Prokopchuk-Gauk, MD, FRCPC, DRCPSC, Kathryn Webert, MD, MSc, FRCPC, Jennifer Grossman, MD, FRCPC

  37–54

  • PDF (en)
  • PDF (fr)